![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Park Duk
Publisher: Springer Publishing Company
ISSN: 0340-5761
Source: Archives of Toxicology, Vol.78, Iss.6, 2004-06, pp. : 306-308
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Gu Shou-Yong Zhang Zhong-Bin Wan Jun-Xiang Jin Xi-Peng Xia Zhao-Lin
Journal of Toxicology and Environmental Health, Vol. 70, Iss. 11, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Gunes Arzu Ozbey Gul Vural Elif Hilal Uluoglu Canan Scordo Maria Gabriella Zengil Hakan Dahl Marja-Liisa
Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
By Lin Keh-Ming Tsou Hsiao-Hui Tsai I-Ju Hsiao Mei-Chun Hsiao Chin-Fu Liu Chia-Yih Shen Winston W Tang Hwa-Sheng Fang Chun-Kai Wu Chi-Shin Lu Shao-Chun Kuo Hsiang-Wei Liu Shu Chih Chan Hsiu-Wen Hsu Ya-Ting Tian Jia-Ni Liu Yu-Li
Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Ghotbi Roza Christensen Magnus Roh Hyung-Keun Ingelman-Sundberg Magnus Aklillu Eleni Bertilsson Leif
European Journal of Clinical Pharmacology, Vol. 63, Iss. 6, 2007-06 ,pp. :